ALBEMARLE CORPORATION

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) December 23, 2005 (December 22, 2005)

 


 

ALBEMARLE CORPORATION

(Exact name of Registrant as specified in charter)

 


 

Virginia   1-12658   54-1692118

(State or other jurisdiction

of incorporation)

  (Commission file number)  

(IRS employer

identification no.)

 

330 South Fourth Street, Richmond, Virginia       23219
(Address of principal executive offices)       (Zip code)

 

Registrant’s telephone number, including area code (804) 788-6000

 

Not applicable

(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officer.

 

On December 22, 2005, Albemarle Corporation (the “Company”) announced, effective January 1, 2006, a realignment of its finance team by creating a chief financial officer position within each of its three main operating segments. As part of this new structure, William B. Allen, Jr., the Company’s current controller and principal accounting officer, will become Chief Financial Officer — Fine Chemicals. Also effective January 1, 2006, Richard J. Diemer, Jr., the Company’s Senior Vice President and Chief Financial Officer, will serve as the Company’s principal financial officer and principal accounting officer. The information required by Item 5.02(c)(2) and (3) of Form 8-K regarding Mr. Diemer is incorporated herein by reference to Item 1.01 of the Current Report on Form 8-K filed by the Company on August 2, 2005.

 

The press release issued on December 22, 2005, by the Company announcing the changes discussed above is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01. Financial Statement and Exhibits.

 

  (c) Exhibits.

 

99.1    Press release issued on December 22, 2005, by the Company.


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 23, 2005

 

ALBEMARLE CORPORATION
By:  

/s/ Luther C. Kissam, IV


    Luther C. Kissam, IV
    Vice President, General Counsel and Secretary


EXHIBIT INDEX

 

Exhibit

Number


 

Exhibit


99.1   Press release issued on December 22, 2005, by the Company.
PRESS RELEASE

EXHIBIT 99.1

 

LOGO   Press Release

 

Albemarle To Realign Finance Team

 

RICHMOND, Virginia—December 22, 2005—Albemarle Corporation (NYSE: ALB) will realign its finance team, effective January 1, 2006, to deliver enhanced support to the company’s business by creating a chief financial officer position within each of its three main operating segments: Fine Chemicals, Polymer Additives and Catalysts.

 

William B. Allen, Jr. will serve as CFO - Fine Chemicals, reporting to John Nicols, Vice President - Fine Chemicals, and Rich Diemer, Senior Vice President and CFO of Albemarle. Allen, who has served as corporate controller since September 2003, has held a number of different positions since joining Albemarle in 1994, including finance director for European, Middle East and African operations as well as corporate director of financial analysis and planning. Allen will remain in Baton Rouge, La., in his new position and will have transitional responsibility for the controllership function through the company’s 2005 annual reporting processes.

 

Steve LeVan will serve as CFO - Polymer Additives, reporting to John Dabkowski, Vice President - Polymer Additives, and Diemer. With over 26 years of experience in the chemical industry, LeVan brings a wealth of knowledge and strategic financial analysis experience to his new position. LeVan joined Albemarle in 2001 as business director of pharmaceuticals and agrichemicals. He then served as global director - pharmaceuticals and, most recently, as director of strategic planning. LeVan will continue to be based out of Baton Rouge.

 

Leon Maas will serve as CFO - Catalysts, reporting to Ray Hurley, Vice President - Catalysts, and Diemer. Maas, who will remain in Albemarle’s offices in Amersfoort, the Netherlands, joined Albemarle through its acquisition of Akzo Nobel’s refinery catalysts business in 2004. After joining Akzo Nobel in 1983, Maas held a variety of financial assignments prior to his serving as business unit controller for Akzo Nobel Catalysts, beginning in 1997.

 

Geoff Stanford has been appointed Corporate Controller, reporting to Diemer. Stanford, based in Albemarle’s Baton Rouge offices, recently joined the company as controller, external reporting and consolidation. Prior to joining Albemarle, Stanford served in corporate controller roles for two public companies after leaving public accounting. In addition to his corporate controllership duties at Albemarle, Stanford will provide regional financial coordination for the company’s operations in Europe and Asia.

 

Albemarle Corporation

330 South Fourth Street

Richmond, Virginia, USA

Tel: +1 804 788 6096


LOGO   Press Release

 

“By deploying talented, seasoned professionals into these critical positions within our operating units, we will be able to better communicate and partner with our global businesses and, in turn, with our customers and other stakeholders,” Diemer said.

 

Albemarle Corporation, headquartered in Richmond, Virginia, is a leading global developer, manufacturer and marketer of bromine, bromine derivatives, and other highly engineered specialty chemicals for consumer electronics; petroleum and petrochemical processing; transportation and industrial products; pharmaceuticals; agricultural products; and construction and packaging materials. The Company operates in three business segments—Polymer Additives, Catalysts and Fine Chemicals, and serves customers in approximately 100 countries. Learn more about Albemarle at http://www.albemarle.com.

 

###

 

For more information:

 

Albemarle Corporation, Ms. Nicole Daniel, Investor Relations, +1 804 788 6096 or nicole.daniel@albemarle.com

 

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation’s business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report on Form 10-K.

 

Albemarle Corporation

330 South Fourth Street

Richmond, Virginia, USA

Tel: +1 804 788 6096